The tweet was deleted by the author.
But we saved everything 🙂.
Myriad Genetics has introduced its FirstGene Multiple Prenatal Screen during ACOG2026, a major medical conference held in Washington, D.C.
The company engaged clinicians and attendees through hands-on activities such as the Claw Machine Challenge, promoting discussions on the future of genetics and insight-driven care. Myriad Genetics highlighted the importance of early prenatal screening as the field of genetic testing continues to evolve.
Myriad previously announced plans to participate in two healthcare conferences in the coming weeks, expanding its industry engagement, according to a recent company statement. At ACOG2026, the firm launched its FirstGene Multiple Prenatal Screen with an interactive demo for clinicians, as detailed in an earlier company release. These efforts are part of Myriad's ongoing push to connect with healthcare professionals on advances in genetic screening.